Proguanil Anti-infection inhibitor

Cat.No.S5927

Proguanil (chlorguanide, chloroguanide) is a prophylactic antimalarial drug. It inhibits the dihydrofolate reductase of plasmodia and thereby blocks the biosynthesis of purines and pyrimidines, which are essential for DNA synthesis and cell multiplication.
Proguanil Anti-infection inhibitor Chemical Structure

Chemical Structure

Molecular Weight: 253.73

Quality Control

Chemical Information, Storage & Stability

Molecular Weight 253.73 Formula

C11H16ClN5

Storage (From the date of receipt) 3 years -20°C powder
CAS No. 500-92-5 -- Storage of Stock Solutions

Synonyms chlorguanide, chloroguanide Smiles CC(C)N=C(N)N=C(N)NC1=CC=C(C=C1)Cl

Solubility

In vitro
Batch:

DMSO : 51 mg/mL (201.0 mM)
(Moisture-contaminated DMSO may reduce solubility. Use fresh, anhydrous DMSO.)

Ethanol : 51 mg/mL

Water : Insoluble

Molarity Calculator

Mass Concentration Volume Molecular Weight

In vivo
Batch:

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

mg/kg
g
μL

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO
%
% Tween 80
% ddH2O
% DMSO
+
%

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.

Mechanism of Action

Clinical Trial Information

(data from https://clinicaltrials.gov, updated on 2024-05-22)

NCT Number Recruitment Conditions Sponsor/Collaborators Start Date Phases
NCT04002687 Completed
Malaria
Medicines for Malaria Venture|Richmond Pharmacology Limited
April 4 2019 Phase 1
NCT01858831 Completed
Malaria
GlaxoSmithKline
April 2012 Phase 1
NCT01456546 Completed
CYP2C19 Genotypes
University of Southern Denmark
October 2011 Phase 1

Tech Support

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.